Status:
COMPLETED
Multimodal Analgesia for Cholecystectomy
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Laparoscopic Cholecystectomy
Eligibility:
All Genders
19+ years
Phase:
PHASE3
Brief Summary
It is important to decrease the postoperative pain in patients undergoing laparoscopic cholecystectomy. We will compare the pharmacologic analgesia with the parmacologic and surgical analgesia in pati...
Eligibility Criteria
Inclusion
- Patients aged 19 years old or older, with American Society of Anesthesiologists Physical Status 1-3, and scheduled for elective laparoscopic cholecystectomy
Exclusion
- Recent gastric ulcer disease
- Hepatic or renal insufficiency
- Opioid dependency
- Coagulopathy
- Pre-existing neurologic or anatomic deficits in the lower extremities
- Severe psychiatric illness
- pregnancy
Key Trial Info
Start Date :
March 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04788654
Start Date
March 17 2021
End Date
July 31 2021
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Do-Hyeong Kim
Seoul, South Korea, seoul